P1.03-005 Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9
| Autor: | Horinouchi, H., Maemondo, M., Hida, T., Takeda, M., Hotta, K., Hirai, F., Kim, Y., Matsumoto, S., Mitsudomi, T., Seto, T., Moizumi, S., Tokushige, K., Hatano, B., Nishio, M. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1952-S1953 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|